I
Insight Horizon Media

What company makes impella

Author

Daniel Johnson

Published Apr 02, 2026

Since 2005 when Abiomed acquired the Impella technology, the heart devices have received a series of FDA approvals. Notably, in 2015, Abiomed received FDA approval to use the Impella 2.5 heart pump during elective and urgent high-risk percutaneous coronary intervention procedures.

Who makes Impella heart pump?

Impella Heart Pump | OSF HealthCare.

What company makes the world's smallest heart pump?

Abiomed’s Impella ECP heart pump, which the company says is fully compatible with small bore access and closure techniques, has been granted the FDA’s breakthrough device designation. The device, which measures just 3 mm long, is billed by Abiomed as “the world’s smallest heart pump.”

Is impella a brand name?

The ABIOMED logo, ABIOMED, Impella, Impella CP, and Impella RP are registered trademarks of Abiomed, Inc. in the U.S. and in certain foreign countries. Impella 2.5, Impella 5.0, and Recovering hearts.

Who invented impella?

Thorsten Siess, Abiomed’s Chief Technology Officer and Inventor of Impella® Shares his Insights on the Impella Platform of Heart Pumps.

What makes you not a candidate for open heart surgery?

You may not be a good candidate if you have a: Pre-existing condition including an aneurysm, heart valve disease, or blood disease. Serious physical disability including an inability to care for yourself. Severe disease of another organ, such as the lungs or kidneys.

What does Impella stand for?

Abstract. Impella (Abiomed, Danvers, MA) is a percutaneously inserted ventricular assist device (VAD). It has been increasingly used in patients with severe heart failure, cardiogenic shock, and high-risk percutaneous intervention (PCI).

When did Impella get FDA approval?

Impella is the world’s smallest heart pump. It first received FDA clearance in 2008 and FDA PMA approval as safe and effective in 2015. During the last 10 years, Impella has provided left ventricular unloading to approximately 10,000 ECMO patients in cardiogenic shock.

Is Impella an implant?

The Impella catheter is implanted into the left side of a patient’s heart through a small incision in the femoral artery (major artery in the leg) or through a small incision in a subclavian artery (an artery in the chest).

How much does an Impella cost?

The approximate device cost of Impella is $23,000–$25,000 and that of IABP is $800–$1000.

Article first time published on

How long can an Impella stay in place?

The FDA has approved use of Impella for 6 hours, but current data has revealed off-label use in patients for a variable duration, ranging from a few hours to an average of 12 days, with the longest recorded duration at 35 days in a single documented case.

When was Impella first used?

Background: Impella was approved for mechanical circulatory support (MCS) in 2008, but large-scale, real-world data on its use are lacking.

What creature has the smallest heart?

The smallest animal hearts belong to the . 006-inch long fairyflies. You need a microscope to see its heart, which is a tube running along its back. A new species of fairyfly found in Costa Rica is named Tinkerbella nana.

What is a TandemHeart?

The TandemHeart is a left atrial-to-femoral artery bypass system comprising a transseptal cannula, arterial cannulae, and a centrifugal blood pump. The pump can deliver flow rates up to 4.0 L/min at a maximum speed of 7500 rpm.

What is the most common type of ventricular assist device?

The LVAD is the most common type of VAD. It helps the left ventricle pump blood to the aorta. The aorta is the main artery that carries oxygen-rich blood from your heart to your body. RVADs usually are used only for short-term support of the right ventricle after LVAD surgery or other heart surgery.

How big is an Impella device?

The Impella 2.5 catheter is 7.5 cm from the pigtail to the aortic annulus marker, thus requiring an LV apical length of 7.5 cm to allow the device to function in an unconstrained fashion.

Who places an Impella?

The Impella heart pump is placed by an interventional cardiologist using standard non-surgical techniques.

How long can a person live with a ventricular assist device?

Left ventricular assist device (LVAD) is usually used to keep a patient alive until a suitable heart donor is found. A patient may stay alive for 5 and a half years with LVAD. As per research, 80–85% of patients are alive a year after having an LVAD placed and 70–75% of patients are alive for 2 years with an LVAD.

Can you do CPR with Impella?

Cardiopulmonary support (CPR) should be initiated immediately per hospital protocol if indicated for any patient supported with the Impella® RP Catheter. When initiating CPR, reduce the Impella® RP Catheter flow rate.

Do they break your ribs for open heart surgery?

Open-heart surgery requires opening the chest wall to make the heart easier for the surgeon to reach. To access the heart, surgeons cut through the sternum (breastbone) and spread the ribs. Sometimes people call this cracking the chest.

Does the sternum grow back together after heart surgery?

During heart surgery, the sternum is split to provide access to the heart. The sternum is wired back together after the surgery to facilitate proper healing. During the healing phase, the wired sternum is vulnerable to the expansion of breathing muscles, which may loosen the wires over time.

What does the scar look like after open heart surgery?

In the beginning the scar will look like a long scab and will be covered by a layer of clear surgical glue (called Dermabond) to keep it safe from infection. This glue will peel off by itself. Remember, it is best not to pick at it. The scab will slowly heal and begin to look more like a scar over the first two months.

Does Impella need anticoagulation?

The Impella heart pumps require a specific purge pressure range (300-1100 mm Hg) for optimal pump flow and a specific systemic ACT anticoagulation range (160-180 seconds) for optimal and sustained function.

What is the success rate of LVAD surgery?

Patient Survival The overall survival on LVAD support was 86.1%, 56.0%, and 30.9% at 30 days, 1 year, and 2 years after LVAD implantation, respectively, as shown in Figure 1. A total of 155 of 280 patients (55%) died during the mean support time of 10.4 months (range, 1 day to 3.6 years).

How is an Impella inserted?

The Impella® blood pump is inserted into the femoral artery through a small incision in the leg. The Impella® blood pump can also be inserted into the subclavian artery through a small incision in the chest. Then it is advanced through the patient’s artery to their heart.

Is impella FDA approved?

Impella LV Support Systems are FDA-approved (PMA approval P140003) to provide temporary LV support in patients undergoing a percutaneous coronary intervention (PCI) procedure5 or in cardiogenic shock. … In addition, COVID-19 patients may require V-V ECMO for pulmonary failure.

What is Impella CP?

Impella CP is a percutaneously inserted left ventricular assist device indicated for temporary mechanical cardiac support during high risk percutaneous coronary interventions and for cardiogenic shock.

Who founded Abiomed?

Abiomed (NSDQ:ABMD) founder and cardiovascular pioneer David Lederman last week died of pancreatic cancer at the age of 68.

Where does the Impella sit in the heart?

The Impella device is a catheter-based miniaturized ventricular assist device. Using a retrograde femoral artery access, it is placed in the left ventricle across the aortic valve.

What makes a PCI high risk?

High-risk PCI was defined as patients meeting one or more of the contemporary criteria described by the Interventional Council of ACC2: unprotected left main coronary artery disease, last remaining patent vessel, LVEF <35%, complex 3-vessel CAD, and comorbidities including severe aortic stenosis or severe mitral …

How do you get rid of Impella?

Traditionally, the Impella® devices are removed via surgical repair of the common femoral artery, or percutaneously with applied pressure at the access site to achieve hemostasis. However, hemostasis can be difficult to obtain with pressure due to large sheath size.